ERROL B DESOUZA Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ERROL B DESOUZA.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ERROL B DESOUZA. ERROL B DESOUZA is Director in CATALYST BIOSCIENCES, INC. ($CBIO) and CEO in Biodel Inc ($BIOD) and in Cyclerion Therapeutics, Inc. ($CYCN) and Director in Royalty Pharma plc ($RPRX).
Latest Insider Trading Transactions of ERROL B DESOUZA
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALBO, CBIO, CYCN, RPRX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 29 2021 | RPRX | Royalty Pharma plc | DESOUZA ERROL B | Director | Grant | A | 0.00 | 5,726 | 0 | 50,370 | 44.6 K to 50.4 K (+12.83 %) |
| Jun 29 2021 | RPRX | Royalty Pharma plc | DESOUZA ERROL B | Director | Grant | A | 0.00 | 5,726 | 0 | 50,370 | 44.6 K to 50.4 K (+12.83 %) |
| Jun 28 2021 | CYCN | Cyclerion Therapeu ... | DESOUZA ERROL B | Option Exercise | A | 3.97 | 10,000 | 39,700 | 10,000 | ||
| Apr 05 2021 | CBIO | CATALYST BIOSCIENC ... | DESOUZA ERROL B | Director | Grant | A | 0.00 | 2,926 | 0 | 22,807 | 19.9 K to 22.8 K (+14.72 %) |
| Jan 06 2021 | CBIO | CATALYST BIOSCIENC ... | DESOUZA ERROL B | Director | Grant | A | 0.00 | 2,129 | 0 | 19,881 | 17.8 K to 19.9 K (+11.99 %) |
| Oct 02 2020 | CBIO | CATALYST BIOSCIENC ... | DESOUZA ERROL B | Director | Grant | A | 0.00 | 3,125 | 0 | 17,752 | 14.6 K to 17.8 K (+21.36 %) |
| Sep 23 2020 | RPRX | Royalty Pharma plc | DESOUZA ERROL B | Director | Option Exercise | A | 0.00 | 53,915 | 0 | 53,915 | |
| Sep 23 2020 | RPRX | Royalty Pharma plc | DESOUZA ERROL B | Director | Grant | A | 0.00 | 8,929 | 0 | 44,644 | 35.7 K to 44.6 K (+25.00 %) |
| Sep 23 2020 | RPRX | Royalty Pharma plc | DESOUZA ERROL B | Director | Option Exercise | A | 0.00 | 53,915 | 0 | 53,915 | |
| Sep 23 2020 | RPRX | Royalty Pharma plc | DESOUZA ERROL B | Director | Grant | A | 0.00 | 8,929 | 0 | 44,644 | 35.7 K to 44.6 K (+25.00 %) |
| Jun 17 2020 | RPRX | Royalty Pharma plc | DESOUZA ERROL B | Director | Grant | A | 0.00 | 35,715 | 0 | 35,715 | 0 to 35.7 K |
| Jun 17 2020 | RPRX | Royalty Pharma plc | DESOUZA ERROL B | Director | Grant | A | 0.00 | 35,715 | 0 | 35,715 | 0 to 35.7 K |
| Jun 12 2020 | CBIO | CATALYST BIOSCIENC ... | DESOUZA ERROL B | Director | Option Exercise | A | 7.18 | 5,000 | 35,900 | 5,000 | |
| Jun 12 2020 | CBIO | CATALYST BIOSCIENC ... | DESOUZA ERROL B | Director | Option Exercise | A | 7.18 | 5,000 | 35,900 | 5,000 | |
| Apr 03 2020 | CBIO | CATALYST BIOSCIENC ... | DESOUZA ERROL B | Director | Grant | A | 0.00 | 2,860 | 0 | 12,498 | 9.6 K to 12.5 K (+29.67 %) |
| Jan 02 2020 | CBIO | CATALYST BIOSCIENC ... | DESOUZA ERROL B | Director | Grant | A | 0.00 | 1,835 | 0 | 9,638 | 7.8 K to 9.6 K (+23.52 %) |
| Jan 02 2020 | CBIO | CATALYST BIOSCIENC ... | DESOUZA ERROL B | Director | Grant | A | 0.00 | 1,835 | 0 | 9,638 | 7.8 K to 9.6 K (+23.52 %) |
| Oct 02 2019 | CBIO | CATALYST BIOSCIENC ... | DESOUZA ERROL B | Director | Grant | A | 0.00 | 2,545 | 0 | 7,803 | 5.3 K to 7.8 K (+48.40 %) |
| Jun 17 2019 | CBIO | CATALYST BIOSCIENC ... | DESOUZA ERROL B | Director | Option Exercise | A | 7.46 | 5,000 | 37,300 | 5,000 | |
| Jan 03 2019 | CBIO | CATALYST BIOSCIENC ... | DESOUZA ERROL B | Director | Grant | A | 0.00 | 1,703 | 0 | 1,944 | 241 to 1.9 K (+706.64 %) |
| Jun 15 2018 | CBIO | CATALYST BIOSCIENC ... | DESOUZA ERROL B | Director | Option Exercise | A | 24.94 | 5,000 | 124,700 | 5,000 | |
| Jul 14 2017 | CBIO | CATALYST BIOSCIENC ... | DESOUZA ERROL B | Director | Option Exercise | A | 4.40 | 10,000 | 44,000 | 10,000 | |
| Jun 13 2016 | CBIO | CATALYST BIOSCIENC ... | DESOUZA ERROL B | Director | Option Exercise | A | 1.88 | 7,500 | 14,100 | 7,500 | |
| Oct 26 2015 | CBIO | CATALYST BIOSCIENC ... | DESOUZA ERROL B | Director | Option Exercise | A | 4.40 | 6,750 | 29,700 | 6,750 | |
| Oct 26 2015 | CBIO | CATALYST BIOSCIENC ... | DESOUZA ERROL B | Director | Option Exercise | A | 4.40 | 8,250 | 36,300 | 8,250 | |
| Oct 02 2015 | BIOD | Biodel Inc | DESOUZA ERROL B | CEO | Payment of Exercise | F | 0.44 | 43,469 | 19,126 | 159,416 | 202.9 K to 159.4 K (-21.43 %) |
| Oct 02 2015 | BIOD | Biodel Inc | DESOUZA ERROL B | CEO | Buy | M | 0.00 | 131,128 | 0 | 202,885 | 71.8 K to 202.9 K (+182.74 %) |
Page: 1